Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
AverageAt Mirion, we deliver vital protection that unlocks the transformative potential of radiation to move science, industry and medicine forward. For more than 60 years Mirion and our predecessor companies have provided products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience.
In the company’s own words · 10-K filed Feb 19, 2026 · SEC EDGAR
Business segments
Q1 2026 · $257.6MThe company’s own SEC segment disclosure.
- Nuclear Power$125.8M49%
- Cancer Care$55.3M21%
- Other Research$31.4M12%
- Labs And Research$28.3M11%
- Other Care$16.8M7%
Mirion Technologies, Inc. (MIR) reported revenue of $258M in Q1 2026 (quarter ended March 31, 2026), up 28% from the same quarter a year earlier. That came with a gross margin of 46% and net loss of $3.4M. For the full year FY2025, revenue was $925M (+7.5% year on year) and net income $29M. Its largest product in 2026-Q1 was Nuclear Power at $126M, 49% of the disclosed total, just ahead of Cancer Care at 21%.
Raw charts
10 series · TTMAs reported to the SEC, without any scoring.
Specialty Industrial Machinery
Ranks #35 of 44 by Smart Score